⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7105090 | 0.85 | SMN1; SMN2 (0.46) | — | |
| SCHEMBL13640440 | 0.80 | CA1 (0.45) | — | |
| SCHEMBL2566028 | 0.80 | — | — | |
| SCHEMBL1731865 | 0.79 | ALDH1A1 (0.40) | — | |
| SCHEMBL11358308 | 0.79 | ALDH1A1 (0.40) | — | |
| SCHEMBL9065139 | 0.78 | CA1 (0.39) | — | |
| SCHEMBL184608 | 0.78 | — | — | |
| SCHEMBL15314124 | 0.78 | — | — | |
| SCHEMBL11375638 | 0.78 | — | — | |
| SCHEMBL7707505 | 0.78 | SMN1; SMN2 (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1305277-A2 | PROCESS FOR THE PREPARATION OF ALKYL 1-METHYLCYCLOPROPANECARBOXYLATE | EASTMAN CHEMICAL COMPANY (US) | 2003-05-02 | — | — | EP | claimed |
| US-6552217-B2 | Process for the preparation of alkyl 1-methylcyclopropanecarboxylate | EASTMAN CHEMICAL COMPANY | 2003-04-22 | — | — | US | claimed |
| WO-2002010116-A2 | PROCESS FOR THE PREPARATION OF ALKYL 1-METHYLCYCLOPROPANECARBOXYLATE | EASTMAN CHEMICAL COMPANY (US) | 2002-02-07 | — | — | WO | claimed |
| US-20020016493-A1 | Process for the preparation of alkyl 1-methylcyclopropanecarboxylate | EASTMAN CHEMICAL COMPANY | 2002-02-07 | — | — | US | claimed |
| WO-2025202022-A9 | ANTICANCER MACROCYCLIC QUINAZOLINE-BASED INHIBITORS OF THE INERACTION BETWEEN RAS AND SOS1 | BAYER AKTIENGESELLSCHAFT (DE) | 2025-12-26 | — | — | WO | disclosed |
| EP-4630410-A1 | POLQ INHIBITORS | Astrazeneca AB (SE) | 2025-10-15 | — | — | EP | disclosed |
| WO-2025202022-A1 | ANTICANCER MACROCYCLIC QUINAZOLINE-BASED INHIBITORS OF THE INERACTION BETWEEN RAS AND SOS1 | BAYER AKTIENGESELLSCHAFT (DE) | 2025-10-02 | — | — | WO | disclosed |
| US-12414954-B2 | POLQ inhibitors | ASTRAZENECA AB (SE) | 2025-09-16 | — | — | US | disclosed |
| US-20250195530-A1 | POLQ INHIBITORS | ASTRAZENECA AB (SE) | 2025-06-19 | — | — | US | disclosed |
| US-20240417388-A1 | BENZIMIDAZOLONE DERIVED INHIBITORS OF BCL6 | CANCER RESEARCH TECH LTD (GB) | 2024-12-19 | — | — | US | disclosed |
| US-20240366615-A1 | POLQ INHIBITORS | ASTRAZENECA UK LIMITED (GB) | 2024-11-07 | — | — | US | disclosed |
| US-12110286-B2 | Benzimidazolone derived inhibitors of BCL6 | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2024-10-08 | — | — | US | disclosed |
| WO-2006112464-A1 | PIPERAZINE-SUBSTITUTED BENZOTHIOPHENES FOR TREATMENT OF MENTAL DISORDERS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-10-26 | — | — | WO | disclosed |
| US-20050256158-A1 | PGD2 receptor antagonists for the treatment of inflammatory diseases | MILLENNIUM PHARMACEUTICALS, INC. | 2005-11-17 | — | — | US | disclosed |
| WO-2005100321-A1 | PGD2 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2005-10-27 | — | — | WO | disclosed |
| EP-1305277-A2 | PROCESS FOR THE PREPARATION OF ALKYL 1-METHYLCYCLOPROPANECARBOXYLATE | EASTMAN CHEMICAL COMPANY (US) | 2003-05-02 | — | — | EP | disclosed |
| US-6552217-B2 | Process for the preparation of alkyl 1-methylcyclopropanecarboxylate | EASTMAN CHEMICAL COMPANY | 2003-04-22 | — | — | US | disclosed |
| WO-2002010116-A2 | PROCESS FOR THE PREPARATION OF ALKYL 1-METHYLCYCLOPROPANECARBOXYLATE | EASTMAN CHEMICAL COMPANY (US) | 2002-02-07 | — | — | WO | disclosed |
| US-20020016493-A1 | Process for the preparation of alkyl 1-methylcyclopropanecarboxylate | EASTMAN CHEMICAL COMPANY | 2002-02-07 | — | — | US | disclosed |
| US-4520209-A | Process for cyclizing upsilon-chlorocarboxylic acids | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1985-05-28 | — | — | US | disclosed |